Treatment strategy for severe and refractory inflammatory bowel disease
Naganuma, M.; Watanabe, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 286-293
2012
ISSN/ISBN: 0047-1852 PMID: 23126105 Document Number: 658500
Document emailed within 1 workday
Related Documents
Sugita, A.; Koganei, K.; Tatsumi, K.; Futatsuki, R.; Kimura, H. 2012: Strategy of surgical treatment for inflammatory bowel disease Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 413-419Taylor, S.; Lobo, A.J. 2016: Diagnosis and treatment of inflammatory bowel disease Practitioner 260(1795): 19-23
Guagnozzi, D.; González-Castillo, S.; Olveira, A.; Lucendo, A.J. 2012: Nutritional treatment in inflammatory bowel disease. An update Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 104(9): 479-488
Trap, R.; Sørensen, S.M.; Kjaergaard, J. 1988: Alternative treatment among patients with inflammatory bowel disease Ugeskrift for Laeger 150(2): 86-88
Weiss, D.J.; Gagne, J.M.; Armstrong, P.J. 1996: Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats Journal of the American Veterinary Medical Association 209(6): 1114-1116
Passalacqua, S.; Ferraro, P.M. 2012: Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29(Suppl 54): S61-S63
Ulrych, J.; Krška, Z. 2012: Idiopathic inflammatory bowel disease - advancements in surgical treatment Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 91(10): 539-544
Frenzer, A. 2011: Inflammatory bowel disease: diagnosis and treatment in general practice Revue Medicale Suisse 7(279): 250-251
Wong, J-Min.; Wei, S-Chen. 2003: Efficacy of Pentasa tablets for the treatment of inflammatory bowel disease Journal of the Formosan Medical Association 102(9): 613-619
Campbell, A.C.; Skinner, J.M.; Hersey, P.; Roberts-Thomson, P.; MacLennan, I.C.; Truelove, S.C. 1974: Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine Clinical and Experimental Immunology 16(4): 521-533
Babb, R.R. 1978: The role of total parenteral nutrition in the treatment of inflammatory bowel disease American Journal of Gastroenterology 70(5): 506-509
Kolacek, S. 2002: Role of enteral nutrition in the treatment of chronic inflammatory bowel disease Medicinski Arhiv 56(1 Suppl 1: 21-22
Treepongkaruna, S.; Pienvichit, P.; Sornmayura, P.; Pornkul, R.; Wisedopas, N.; Phuapradit, P. 2006: Inflammatory bowel disease in Thai children: presentations and outcomes of treatment Asian Pacific Journal of Allergy and Immunology 24(1): 73-79
Asakura, H.; Sugimura, K. 1999: Present states of development in new drugs and treatment of inflammatory bowel disease Nihon Rinsho. Japanese Journal of Clinical Medicine 57(11): 2490-2495
Kubota, Y.; Saito, H.; Sawada, T.; Muto, T. 1991: Parenteral and enteral nutrition for conservative treatment of inflammatory bowel disease Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 393-398
Kubota, Y.; Saito, H.; Sawada, T.; Muto, T. 1991: Parenteral and enteral nutrition in the surgical treatment of inflammatory bowel disease Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 388-392
Silberer, H.; Küppers, B.; Mickisch, O.; Baniewicz, W.; Drescher, M.; Traber, L.; Kempf, A.; Schmidt-Gayk, H. 2005: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clinical Laboratory 51(3-4): 117-126
Walker, E.A.; Katon, W.J.; Roy-Byrne, P.P.; Jemelka, R.P.; Russo, J. 1993: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease American Journal of Psychiatry 150(10): 1502-1506
Yamamoto-Furusho, J.K.; Bosques-Padilla, F.; Alberro, M.; Armienta, R.; Bernal, Rúl.; Bielsa, Mía.Victoria.; Blas, M.; Bosques, F.; Charúa, L.; Cortés, Tás.; de Ariño, M.; Lira, M.Antonio.; Malé, Ré.; Orozco, A.; Manauta, J.Pérez.; Noble, A.; Ramos, M.; Raña, R.; Rivera, J.; Rocha, Jé.Luis.; Rojas, Més.; Tamayo, Jé.Luis.; Teramoto, O.; Uscanga, L.Federico.; Vásquez, E.; Yamamoto Furusho, K.; Zárate, A.Rosa. 2009: Mexican consensus on the use of agents anti-TNF-alpha in the treatment of inflammatory bowel disease. Revista de Gastroenterologia de Mexico 74(3): 263-278
Rasmussen, S.N.; Bondesen, S.; Nielsen, O.H.; Binder, V.; Hansen, S.H.; Hvidberg, E. 1985: 5-amino-salicylic acid. a review of a new treatment of chronic inflammatory bowel disease Ugeskrift for Laeger 147(36): 2811-2815